Reiterated Outperform X

GILD Gilead Sciences

Oppenheimer

$115 $132

Upgrades Hold Buy X

GILD Gilead Sciences

Deutsche Bank

$120

Upgrades Hold Buy X

GILD Gilead Sciences

DZ Bank

$108

Upgrades Eq-Weight Overweight X

GILD Gilead Sciences

Morgan Stanley

$87 $113

Resumed Buy X

GILD Gilead Sciences

BofA Securities

$109

Initiated Outperform X

GILD Gilead Sciences

Wolfe Research

$110

Initiated Buy X

GILD Gilead Sciences

Citigroup

$125

Downgrades Buy Hold X

GILD Gilead Sciences

Maxim Group

Upgrades Mkt Perform Outperform X

GILD Gilead Sciences

Leerink Partners

$74 $96

Initiated Outperform X

GILD Gilead Sciences

Bernstein

$105

Upgrades Eq Weight Overweight X

GILD Gilead Sciences

Wells Fargo

$78 $100

Upgrades Mkt Perform Outperform X

GILD Gilead Sciences

Raymond James

$93

Reiterated Buy X

GILD Gilead Sciences

Maxim Group

$90 $85

Upgrades Reduce Hold X

GILD Gilead Sciences

HSBC Securities

$69

Downgrades Buy Hold X

GILD Gilead Sciences

Truist

$91 $82

Initiated Hold X

GILD Gilead Sciences

Deutsche Bank

$75

Upgrades Neutral Buy X

GILD Gilead Sciences

BofA Securities

$88 $95

Initiated Reduce X

GILD Gilead Sciences

HSBC Securities

$71

Reiterated Equal Weight X

GILD Gilead Sciences

Barclays

$81 $80

Upgrades Mkt Perform Outperform X

GILD Gilead Sciences

BMO Capital Markets

$90 $100

Resumed Overweight X

GILD Gilead Sciences

Piper Sandler

$105

Downgrades Outperform Sec Perform X

GILD Gilead Sciences

RBC Capital Mkts

$87

Resumed Neutral X

GILD Gilead Sciences

BofA Securities

$85

Downgrades Buy Hold X

GILD Gilead Sciences

DZ Bank

$90

Upgrades Underweight Eq Weight X

GILD Gilead Sciences

Barclays

$60 $76

Reiterated Market Perform X

GILD Gilead Sciences

BMO Capital Markets

$63 $72

Reiterated Outperform X

GILD Gilead Sciences

Cowen

$75 $80

Reiterated Buy X

GILD Gilead Sciences

Jefferies

$78 $86

Reiterated Overweight X

GILD Gilead Sciences

JP Morgan

$80 $87

Upgrades Neutral Overweight X

GILD Gilead Sciences

Piper Sandler

$79 $96

Reiterated Outperform X

GILD Gilead Sciences

RBC Capital Mkts

$79 $82

Upgrades Hold Buy X

GILD Gilead Sciences

Truist

$76 $91

Reiterated Equal Weight X

GILD Gilead Sciences

Wells Fargo

$74 $75

Upgrades Neutral Overweight X

GILD Gilead Sciences

JP Morgan

$72 $80

Initiated Neutral X

GILD Gilead Sciences

Cantor Fitzgerald

$70

Initiated Mkt Perform X

GILD Gilead Sciences

SVB Leerink

$68

Reiterated Outperform X

GILD Gilead Sciences

BMO Capital Markets

$85 $75

Reiterated Neutral X

GILD Gilead Sciences

BofA Securities

$73 $71

Reiterated Outperform X

GILD Gilead Sciences

RBC Capital Mkts

$87 $85

Reiterated Hold X

GILD Gilead Sciences

Truist

$77 $75

Reiterated Equal Weight X

GILD Gilead Sciences

Wells Fargo

$72 $70

Downgrades Overweight Eq-Weight X

GILD Gilead Sciences

Morgan Stanley

$84 $74

Resumed Equal Weight X

GILD Gilead Sciences

Wells Fargo

$72

Upgrades Mkt Perform Outperform X

GILD Gilead Sciences

BMO Capital Markets

$72 $85

Resumed Neutral X

GILD Gilead Sciences

Piper Sandler

$77

Resumed Outperform X

GILD Gilead Sciences

Cowen

Reiterated Market Perform X

GILD Gilead Sciences

BMO Capital Markets

$67 $72

Reiterated Outperform X

GILD Gilead Sciences

RBC Capital Mkts

$81 $84

Upgrades Mkt Perform Outperform X

GILD Gilead Sciences

Bernstein

$80

Upgrades Neutral Buy X

GILD Gilead Sciences

Redburn

Upgrades Eq-Weight Overweight X

GILD Gilead Sciences

Morgan Stanley

$83

Upgrades Neutral Buy X

GILD Gilead Sciences

Guggenheim

Upgrades Outperform Top Pick X

GILD Gilead Sciences

RBC Capital Mkts

$91

Upgrades Mkt Perform Outperform X

GILD Gilead Sciences

Wells Fargo

$68 $88

Downgrades Neutral Sell X

GILD Gilead Sciences

Goldman

Upgrades Neutral Buy X

GILD Gilead Sciences

Citigroup

Initiated Neutral X

GILD Gilead Sciences

Credit Suisse

$70

Initiated Outperform X

GILD Gilead Sciences

Bernstein

$82

Upgrades Neutral Buy X

GILD Gilead Sciences

UBS

$75 $77

Downgrades Buy Neutral X

GILD Gilead Sciences

Citigroup

$100 $75

Downgrades Outperform Mkt Perform X

GILD Gilead Sciences

Wells Fargo

$95 $68

Upgrades Perform Outperform X

GILD Gilead Sciences

Oppenheimer

$85

Reiterated Overweight X

GILD Gilead Sciences

Barclays

$90 $95

Downgrades Overweight Neutral X

GILD Gilead Sciences

Piper Jaffray

Initiated Overweight X

GILD Gilead Sciences

Cantor Fitzgerald

$87

Downgrades Outperform Neutral X

GILD Gilead Sciences

Robert W. Baird

$79

Initiated Strong Buy X

GILD Gilead Sciences

Raymond James

Reiterated Buy X

GILD Gilead Sciences

Maxim Group

$94 $89

Reiterated Overweight X

GILD Gilead Sciences

Barclays

$90 $95

Reiterated Mkt Perform X

GILD Gilead Sciences

Leerink Partners

$83 $80

Reiterated Buy X

GILD Gilead Sciences

Mizuho

$83 $95

Reiterated Buy X

GILD Gilead Sciences

Citigroup

$103 $105

GILD  Gilead Sciences, Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.